Less than 35 percent of all biotech companies have sufficient finances to survive beyond one year.
Wendy Porter
Advertisement
Articles by Wendy Porter
Advertisement
Latest Updated Articles
The CRO Advantage: Outsource Clinical Trials to Launch Biotech Development SuccessPublished: June 1st 2005 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
4
Analytics, Automation, and Quality Driving the Next Era of Drug Development
5
